Quantitative analysis of cryptic splicing associated with TDP-43 depletion

被引:68
|
作者
Humphrey, Jack [1 ,2 ]
Emmett, Warren [1 ,3 ,4 ]
Fratta, Pietro [5 ]
Isaacs, Adrian M. [2 ]
Plagnol, Vincent [1 ]
机构
[1] UCL, Genet Inst, Gower St, London, England
[2] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[3] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England
[4] Francis Crick Inst, Midland Rd, London, England
[5] UCL Inst Neurol, Dept Motor Neurosci & Movement Disorders, Queen Sq, London, England
基金
英国医学研究理事会; 欧洲研究理事会; 英国惠康基金;
关键词
RNA-seq; Cryptic exons; Splicing; TDP-43; MESSENGER-RNA DECAY; HUMAN-DISEASE GENES; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; MUTATION PATTERN; INTRON RETENTION; PROTEINS; EXPRESSION; BINDING; TRANSCRIPTOME;
D O I
10.1186/s12920-017-0274-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Reliable exon recognition is key to the splicing of pre-mRNAs into mature mRNAs. TDP-43 is an RNA-binding protein whose nuclear loss and cytoplasmic aggregation are a hallmark pathology in amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). TDP-43 depletion causes the aberrant inclusion of cryptic exons into a range of transcripts, but their extent, relevance to disease pathogenesis and whether they are caused by other RNA-binding proteins implicated in ALS/FTD are unknown. Methods: We developed an analysis pipeline to discover and quantify cryptic exon inclusion and applied it to publicly available human and murine RNA-sequencing data. Results: We detected widespread cryptic splicing in TDP-43 depletion datasets but almost none in another ALS/FTD-linked protein FUS. Sequence motif and iCLIP analysis of cryptic exons demonstrated that they are bound by TDP-43. Unlike the cryptic exons seen in hnRNP C depletion, those repressed by TDP-43 cannot be linked to transposable elements. Cryptic exons are poorly conserved and inclusion overwhelmingly leads to non-sensemediated decay of the host transcript, with reduced transcript levels observed in differential expression analysis. RNA-protein interaction data on 73 different RNA-binding proteins showed that, in addition to TDP-43, 7 specifically bind TDP-43 linked cryptic exons. This suggests that TDP-43 competes with other splicing factors for binding to cryptic exons and can repress cryptic exon inclusion. Conclusions: Our quantitative analysis pipeline confirms the presence of cryptic exons during the depletion of TDP-43 but not FUS providing new insight into to RNA-processing dysfunction as a cause or consequence in ALS/FTD.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] TDP-43 mediated synaptic alterations in the pathogenesis TDP-43 proteinopathies
    Blizzard, C.
    Handley, E.
    Dawkins, E.
    Clark, R.
    Fielder, T.
    Turner, B.
    Dickson, T.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 195 - 195
  • [22] Ubiquitinated TDP-43 is associated with FTLD and ALS
    Nature Clinical Practice Neurology, 2007, 3 (1): : 7 - 8
  • [23] Decoding TDP-43 Dependent Cryptic Splicing in Amyotrophic Lateral Sclerosis and Identifying Novel Disease-causing Genes
    Yalamanchili, Hari Krishna
    Jeong, Hyun-Hwan
    Liu, Zhandong
    ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, 2018, : 612 - 612
  • [24] Propagation of TDP-43
    Brettschneider, J.
    BRAIN PATHOLOGY, 2014, 24 : 13 - 13
  • [25] TDP-43 Prions
    Nonaka, Takashi
    Hasegawa, Masato
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (03):
  • [26] The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo
    Sasaguri, Hiroki
    Chew, Jeannie
    Xu, Ya-Fei
    Gendron, Tania F.
    Garrett, Aliesha
    Lee, Chris W.
    Jansen-West, Karen
    Bauer, Peter O.
    Perkerson, Emilie A.
    Tong, Jimei
    Stetler, Caroline
    Zhang, Yong-Jie
    BRAIN RESEARCH, 2016, 1647 : 57 - 64
  • [27] TDP-43 Associated Hippocampal Atrophy Evaluated with FreeSurfer Subfield Analysis
    Sahoo, Aradhana
    Whitwell, Jennifer L.
    Tosakulwong, Nirubol
    Weigand, Stephen D.
    Murray, Melissa E.
    Petrucelli, Leonard
    Senjem, Matthew L.
    Spychalla, Anthony J.
    Parisi, Joseph E.
    Knopman, David S.
    Petersen, Ronald C.
    Dickson, Dennis W.
    Jack, Clifford R.
    Josephs, Keith A.
    ANNALS OF NEUROLOGY, 2018, 84 : S144 - S145
  • [28] Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD
    Cao, Tianyu
    Mallika, Aswathy
    Sinha, Irika
    Baghel, Meghraj
    Irwin, Katie
    Ling, Jonathan
    Wong, Philip C.
    MOLECULAR THERAPY, 2024, 32 (04) : 487 - 487
  • [29] The N-terminal dimerization is required for TDP-43 splicing activity
    Jiang, Lei-Lei
    Xue, Wei
    Hong, Jun-Ye
    Zhang, Jun-Ting
    Li, Min-Jun
    Yu, Shao-Ning
    He, Jian-Hua
    Hu, Hong-Yu
    SCIENTIFIC REPORTS, 2017, 7
  • [30] The N-terminal dimerization is required for TDP-43 splicing activity
    Lei-Lei Jiang
    Wei Xue
    Jun-Ye Hong
    Jun-Ting Zhang
    Min-Jun Li
    Shao-Ning Yu
    Jian-Hua He
    Hong-Yu Hu
    Scientific Reports, 7